# Insulin Icodec Initiation Strategies and Day-4 Supplemental Dosing in Type 2 Diabetes

> **NCT07747402** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Xi'an International Medical Center Hospital** · enrollment: 462 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Insulin icodec

## Key facts

- **NCT ID:** NCT07747402
- **Lead sponsor:** Xi'an International Medical Center Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-01
- **Primary completion:** 2027-10
- **Final completion:** 2028-03
- **Target enrollment:** 462 (ESTIMATED)
- **Last updated:** 2026-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07747402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07747402, "Insulin Icodec Initiation Strategies and Day-4 Supplemental Dosing in Type 2 Diabetes". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07747402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*